These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24653848)

  • 1. Improvement with infliximab of a disseminated sarcoidosis in a patient with Crohn's disease.
    Chebib N; Piégay F; Traclet J; Mion F; Mornex JF
    Case Rep Pulmonol; 2014; 2014():368780. PubMed ID: 24653848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of pulmonary sarcoidosis in Crohn's disease patient under infliximab biosimilar treatment after long-term original infliximab treatment: a case report and literature review.
    Kashima S; Moriichi K; Ando K; Ueno N; Tanabe H; Yuzawa S; Fujiya M
    BMC Gastroenterol; 2021 Oct; 21(1):373. PubMed ID: 34641810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphomatoid Papulosis Type B in a Patient with Crohn's Disease Treated with TNF-Alpha Inhibitors Infliximab and Adalimumab.
    Medvecz M; Kiss N; Hársing J; Kuroli E; Hegede G; Csomor J; Kárpáti S; Marschalkó M
    Acta Dermatovenerol Croat; 2019 Sep; 27(3):202-204. PubMed ID: 31542070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous development of sarcoidosis and cutaneous vasculitis in a patient with refractory Crohn's disease during infliximab therapy.
    Numakura T; Tamada T; Nara M; Muramatsu S; Murakami K; Kikuchi T; Kobayashi M; Muroi M; Okazaki T; Takagi S; Eishi Y; Ichinose M
    BMC Pulm Med; 2016 Feb; 16():30. PubMed ID: 26864464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcoidosis during infliximab therapy for Crohn's disease.
    Takahashi H; Kaneta K; Honma M; Ishida-Yamamoto A; Ashida T; Kohgo Y; Ohsaki Y; Iizuka H
    J Dermatol; 2010 May; 37(5):471-4. PubMed ID: 20536653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Crohn's Disease or Crohn's Disease with Lung Sarcoidosis? A Case Report and Literature Review.
    Vlăsceanu S; Bobocea A; Petreanu CA; Bădărău IA; Moldovan H; Gheorghiță D; Antoniac IV; Mirea L; Diaconu CC; Savu C
    Healthcare (Basel); 2022 Nov; 10(11):. PubMed ID: 36421591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Remarkable Response of Granulomatous Hypophysitis to Infliximab in a Patient With a Background of Crohn's Disease-A Case Report.
    Force BK; Vogel TP; Nguyen DM; Heck KA; Sebastian S; Takashima M; Yoshor D; Samson SL
    Front Endocrinol (Lausanne); 2020; 11():350. PubMed ID: 32547497
    [No Abstract]   [Full Text] [Related]  

  • 8. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare paradoxical adverse event in Crohn's disease: a case report.
    Okoshi M; Sato H; Honma T; Terai S
    Ann Transl Med; 2020 Feb; 8(4):133. PubMed ID: 32175426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful primary infliximab treatment of orofacial Crohn's disease without gastrointestinal manifestation].
    Jung BY; Lee SH; Chung SK; Lee CK; Lee TH; Chung IK; Kim SJ; Cho HD
    Korean J Gastroenterol; 2012 Jun; 59(6):437-40. PubMed ID: 22735878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case of Breast Cancer Following Infliximab Treatment for Treatment-Refractory Crohn's Disease.
    Goral V; Unsal B; Nermin Sivrikoz O
    Euroasian J Hepatogastroenterol; 2014; 4(2):104-106. PubMed ID: 29699358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
    Behm BW; Bickston SJ
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006893. PubMed ID: 18254120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-TNF-α antibodies improve intestinal barrier function in Crohn's disease.
    Noth R; Stüber E; Häsler R; Nikolaus S; Kühbacher T; Hampe J; Bewig B; Schreiber S; Arlt A
    J Crohns Colitis; 2012 May; 6(4):464-9. PubMed ID: 22398062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapy for orolaryngeal manifestations of Crohn's disease.
    Ottaviani F; Schindler A; Capaccio P; Petrone M; Bianchi Porro G
    Ann Otol Rhinol Laryngol; 2003 Jan; 112(1):37-9. PubMed ID: 12537056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two patients with new granulomatous lung lesions during treatment of Crohn's disease.
    Takeda S; Akagi T; Miyazaki H; Kodama M; Yamamoto S; Beppu T; Nagahama T; Matsui T; Watanabe K; Nagata N
    Respir Med Case Rep; 2014; 12():16-8. PubMed ID: 26029529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcoid-like lymphocytosis of the lower respiratory tract in patients with active Crohn's disease.
    Smiéjan JM; Cosnes J; Chollet-Martin S; Soler P; Basset FM; Le Quintrec Y; Hance AJ
    Ann Intern Med; 1986 Jan; 104(1):17-21. PubMed ID: 3940500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcending conventional therapies: the role of biologic and other novel therapies.
    Sandborn WJ
    Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S9-16. PubMed ID: 11380043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease].
    Rozpondek P; Zwolińska-Wcisło M; Przybylska M; Mach T
    Przegl Lek; 2011; 68(9):602-5. PubMed ID: 22335009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical Arthralgia Secondary to Anti-Tumor-Necrosis-Factor Alpha Therapy in Crohn's Disease.
    Thurlapati A; Gandu SSK; Kulkarni S
    Cureus; 2021 Jun; 13(6):e15835. PubMed ID: 34327073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.